Learning Objectives, Esketamine, TCPR, January 2020

January 13, 2020

After reading these articles, you should be able to:

  1. Evaluate the safety and efficacy of esketamine as an interventional therapy for treatment resistant depression.

  2. Assess and treat tardive dyskinesia in patients on antipsychotics.

  3. Identify the optimal duration of antipsychotic augmentation in mood disorders.

  4. Summarize some of the current research on psychiatric treatment.

General Psychiatry
    Featured Book
    Featured Video
    Featured Podcast
    Recommended

    About

    Shop Online

    Newsletters

    Contact

    carlat@thecarlatreport.com

    866-348-9279

    PO Box 626, Newburyport MA 01950

    Follow Us

    Please see our Terms and Conditions, Privacy Policy, Subscription Agreement, Use of Cookies, and Hardware/Software Requirements to view our website.

    © 2025 Carlat Publishing, LLC and Affiliates, All Rights Reserved.